275 related articles for article (PubMed ID: 14976251)
1. Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene.
Liu Z; Hergenhahn M; Schmeiser HH; Wogan GN; Hong A; Hollstein M
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2963-8. PubMed ID: 14976251
[TBL] [Abstract][Full Text] [Related]
2. UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin.
Luo JL; Tong WM; Yoon JH; Hergenhahn M; Koomagi R; Yang Q; Galendo D; Pfeifer GP; Wang ZQ; Hollstein M
Cancer Res; 2001 Nov; 61(22):8158-63. PubMed ID: 11719445
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors.
Liu Z; Muehlbauer KR; Schmeiser HH; Hergenhahn M; Belharazem D; Hollstein MC
Cancer Res; 2005 Apr; 65(7):2583-7. PubMed ID: 15805253
[TBL] [Abstract][Full Text] [Related]
4. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M
Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961
[TBL] [Abstract][Full Text] [Related]
5. Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences.
Feldmeyer N; Schmeiser HH; Muehlbauer KR; Belharazem D; Knyazev Y; Nedelko T; Hollstein M
Mutat Res; 2006 Sep; 608(2):163-8. PubMed ID: 16835015
[TBL] [Abstract][Full Text] [Related]
6. Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model.
Kucab JE; Phillips DH; Arlt VM
FEBS J; 2010 Jun; 277(12):2567-83. PubMed ID: 20553493
[TBL] [Abstract][Full Text] [Related]
7. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin.
Kress S; Sutter C; Strickland PT; Mukhtar H; Schweizer J; Schwarz M
Cancer Res; 1992 Nov; 52(22):6400-3. PubMed ID: 1423288
[TBL] [Abstract][Full Text] [Related]
8. TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.
Kucab JE; van Steeg H; Luijten M; Schmeiser HH; White PA; Phillips DH; Arlt VM
Mutat Res; 2015 Mar; 773():48-62. PubMed ID: 25847421
[TBL] [Abstract][Full Text] [Related]
9. Patches of mutant p53-immunoreactive epidermal cells induced by chronic UVB Irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice.
Kramata P; Lu YP; Lou YR; Singh RN; Kwon SM; Conney AH
Cancer Res; 2005 May; 65(9):3577-85. PubMed ID: 15867351
[TBL] [Abstract][Full Text] [Related]
10. Chronic ultraviolet exposure-induced p53 gene alterations in Sencar mouse skin carcinogenesis model.
Tong Y; Smith MA; Tucker SB
J Toxicol Environ Health; 1997 Jun; 51(3):219-34. PubMed ID: 9183379
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-methylcytosine in sunlight-induced mutagenesis.
You YH; Li C; Pfeifer GP
J Mol Biol; 1999 Oct; 293(3):493-503. PubMed ID: 10543945
[TBL] [Abstract][Full Text] [Related]
12. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
13. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
Besaratinia A; Bates SE; Pfeifer GP
Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
[TBL] [Abstract][Full Text] [Related]
14. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
15. Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53.
Jaworski M; Hailfinger S; Buchmann A; Hergenhahn M; Hollstein M; Ittrich C; Schwarz M
Carcinogenesis; 2005 Oct; 26(10):1829-34. PubMed ID: 15917304
[TBL] [Abstract][Full Text] [Related]
16. The carcinogenic air pollutant 3-nitrobenzanthrone induces GC to TA transversion mutations in human p53 sequences.
vom Brocke J; Krais A; Whibley C; Hollstein MC; Schmeiser HH
Mutagenesis; 2009 Jan; 24(1):17-23. PubMed ID: 18765419
[TBL] [Abstract][Full Text] [Related]
17. High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity.
Kanjilal S; Pierceall WE; Cummings KK; Kripke ML; Ananthaswamy HN
Cancer Res; 1993 Jul; 53(13):2961-4. PubMed ID: 8319202
[TBL] [Abstract][Full Text] [Related]
18. Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72.
Reinbold M; Luo JL; Nedelko T; Jerchow B; Murphy ME; Whibley C; Wei Q; Hollstein M
Oncogene; 2008 Apr; 27(19):2788-94. PubMed ID: 17998932
[TBL] [Abstract][Full Text] [Related]
19. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
20. Aflatoxin-B exposure does not lead to p53 mutations but results in enhanced liver cancer of Hupki (human p53 knock-in) mice.
Tong WM; Lee MK; Galendo D; Wang ZQ; Sabapathy K
Int J Cancer; 2006 Aug; 119(4):745-9. PubMed ID: 16557586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
